MDWD News and Press, MediWound Ltd. From 08/14/25

2025-08-14 07:07:11 ET More on MediWound MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript MediWound Ltd.: Undervalued High-Growth Potential MediWound Q2 2025 Earnings Preview MediWound Q1 2025 Earnings Preview Seeking Alpha’s Quant Rating...

Century Therapeutics Inc. (IPSC) is expected to report $-0.38 for Q2 2025 Birchtech Corp Com (BCHT) is expected to report for Q2 2025 Cellectar Biosciences Inc. (CLRB) is expected to report $-3.6 for Q2 2025 Acuren Corporation (TIC) is expected to report for quarter end 2025-06-30 ...

VALUE Phase III Trial of EscharEx ® in Venous Leg Ulcers Continues to Enroll Patients NexoBrid ® Manufacturing Expansion on Track; Full Operational Capacity Expected by Year-End 2025 Additional Strategic Research Collaborations Established with Es...

MediWound Ltd. (MDWD) is expected to report $-0.55 for Q2 2025

2025-08-13 18:00:29 ET Major earnings expected before the bell on Thursday include: JD.com ( JD ) Deere & Company ( DE ) First Majestic Silver Corp. ( AG ) Tapestry ( TPR ) NetEase ( NTES ) Read the full article on Seeking Alpha Fo...

2025-08-13 10:41:36 ET More on MediWound MediWound Ltd. (MDWD) Q1 2025 Earnings Call Transcript MediWound Ltd.: Undervalued High-Growth Potential MediWound Q1 2025 Earnings Preview Seeking Alpha’s Quant Rating on MediWound Historical earnings d...

MediWound Announces New EscharEx ® Phase II Data Demonstrating Strong Link Between Wound Bed Preparation and Wound Closure in Venous Leg Ulcers Post hoc analysis published in Advances in Wound Care, provides clinical evidence supporting wound bed preparation as a critical...

MediWound to Report Second Quarter 2025 Financial Results Conference call and webcast scheduled for Thursday, August 14 at 8:30 a.m. Eastern Time YAVNE, Israel, August 4, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue ...

2025-06-26 04:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-06-12 10:23:46 ET I last looked at a small cap called Vericel Corporation ( VCEL ) in late 2024. I slapped a 'Sell' rating on the stock at the time as its valuation was getting extreme despite its growth. The shares have fallen some 20% since then. The company h...